Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Shanghai Chenguang Medical Technologies Co.,LTD
company
About
Shanghai Chenguang Medical Technologies Co.,LTD is an MRI superconducting magnet and RF detector development company.
- 251 - 500
Details
- Last Funding Type
- Post-IPO Equity
- Last Funding Money Raised
- ¥50.56M
- Industries
- Health Care,Medical,Medical Device
- Founded date
- Aug 3, 2004
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
¥80.56M
Shanghai Chenguang Medical Technologies Co.,LTD has raised a total of
¥80.56M
in funding over 2 rounds. Their latest funding was raised on
Jun 19, 2015 from a Post-IPO Equity round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 19, 2015 | Post-IPO Equity | ¥50.56M | 5 | — | — | Detail |
| Jun 5, 2013 | Post-IPO Equity | ¥30M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
6
Shanghai Chenguang Medical Technologies Co.,LTD is funded by 6 investors.
Zhushan Equity Investment
and Win Share Asset
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Post-IPO Equity |
Win Share Asset
|
— | Post-IPO Equity |
Forest Sun Asset
|
— | Post-IPO Equity |
Yiyuan Investment Holding
|
— | Post-IPO Equity |
Baoying Fund
|
— | Post-IPO Equity |
Haitong-Fortis Private Equity Fund Management
|
— | Post-IPO Equity |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
